AMYRIS BIOTECHNOLOGIES

CA

Biotechnology company.

Active 2007–2010. The register lists this client once for every firm that files on its behalf; all 3 of its records are shown together here.

Filings
27
Filed By
3
Reported In-House
$360,000
Reported By Firms
$200,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2010 BROWNSTEIN HYATT FARBER SCHRECK, LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$20,000
2010 BROWNSTEIN HYATT FARBER SCHRECK, LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$20,000
2010 BROWNSTEIN HYATT FARBER SCHRECK, LLP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$20,000
2010 BROWNSTEIN HYATT FARBER SCHRECK, LLP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$20,000
2009 BROWNSTEIN HYATT FARBER SCHRECK, LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$20,000
2009 BROWNSTEIN HYATT FARBER SCHRECK, LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$20,000
2009 BAY BRIDGE STRATEGIES, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Termination
$10,000
2009 BROWNSTEIN HYATT FARBER SCHRECK, LLP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$20,000
2009 AMYRIS BIOTECHNOLOGIES, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Termination (No Activity)
—
2009 BAY BRIDGE STRATEGIES, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$10,000
Page 1 of 3  ·  27 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings